① Fosun Health said it has no comment on the spin-off listing plan. ② Fosun Health includes 5 major sectors, involving the health consumer industry, mother and child industry, health insurance and health management, overseas medical services, and global innovation investment.
“Science and Technology Innovation Board Daily”, December 21 (Reporter Chen Mei) Recently, there was news that Fosun Pharmaceutical (02196.HK) is considering spin-off Shanghai Fosun Health Technology (Group) Co., Ltd. (Fosun Health) Co., Ltd. (Fosun Health), which is engaged in mainland hospital business, and is going public in Hong Kong and carrying out a new round of financing.
The “Science and Technology Innovation Board Daily” reporter asked Fosun Health about this, and it said, “There is no comment.” However, there are still sources that say that Fosun does have plans to spin-off Fosun Health and go public independently. Also, according to Bloomberg, Fosun Health has now contacted potential investors to assess investor interest and is expected to raise about 1 billion yuan.
According to financing data, Fosun Health was founded in 2019 and completed the first round of financing in May 2020. At that time, Foshan Chancheng District Central Hospital, Fosun Pharmaceutical, and Fosun Group took the initiative to complete their equity financing.
In his view, Fosun Pharmaceutical's spin-off of Fosun Health is not entirely impossible. “On the one hand, the Fosun system already has spin-off genes. Currently, it has four major sub-sectors: Yuyuan, Fosun Pharmaceuticals, Fosun Portugal Insurance, and Fosun Travel and Literature; on the other hand, Pharmacomin Kangde, which is good at spin-off, previously spun off Pharmaceutics Union. The latter was successfully listed on the Hong Kong Stock Exchange and received a lot of long-term capital and subscriptions from major international institutions.”
Fosun Health currently includes 5 major sectors, covering the health consumer industry, the mother and child industry, health insurance and health management, overseas medical services, and global innovation investments. **
In the health consumer industry, Fosun Health has invested in Sanyuan Foods, France's St Hubert Food Company, and British Baby Products Silver Cross; in health insurance and health management, there is Fosun Joint Health Insurance.
According to an announcement on October 13, the assessed asset value of Fosun Allied Health Insurance at the end of 2022 was 1.35 billion yuan. The purpose of the assessment was to increase capital. With this capital increase, Fosun United Insurance has also introduced Guangzhou Nansha Kejin Holding Group (Nansha Kejin for short) and Fosun Pharmaceutical. The former is a strong direct investment parent fund in the Greater Bay Area.
In terms of overseas medical services and global investments, its Portuguese healthcare, Luz Saúde Group, successfully spun off and listed in September this year. In terms of global investment, early investment, primary and secondary market investment, and strategy are all within Fosun Health's range, and it focuses on investing in overseas medical services, consumer health products, and healthcare asset management tracks...
The “Science and Technology Innovation Board Daily” reporter telephoned the staff of Fosun Pharmaceutical's directors' office. They said that although the pharmaceutical block is the core business, the health sector can form a closed loop in the value chain. “From a business perspective, pharmaceuticals are high-investment and high-cycle, while health is a relatively stable asset. At the same time, judging from capitalization methods, a spin-off listing can provide more financing channels to support the development of the business sector.”